Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
biopharma
biotech
clinical trials
deals
drugs
duchenne
europe blog main
europe top stories
fda
givosiran
licensing
m&a
muscular dystrophy
national top stories
onpattro
patisiran
paul matteis
rna interference
roche
sarepta therapeutics
stifel financial
What
approval
2
×
fda
medicine
rna
2
×
second
ago
alnylam
betting
billion
biopharma
deal
drug
duchenne
gene
historic
indicated
interference
nod
pharmaceuticals
puts
quick
recently
rnai
roche
sarepta
seek
speedy
swiss
therapeutics
therapy
weeks
won
won’t
Language
unset
Current search:
rna
×
approval
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
